This inventor holds 1 USPTO granted patent. Top assignees: Teijin Limited, The University of Arizona. Active years: 1994.
Company Filing History:
1 out of 1,605 
1 out of 1,053 Years Active: 1994
Title: Eskild A Peterson: Innovator in Monoclonal Antibodies
Introduction
Eskild A Peterson is a notable inventor based in Tucson, AZ (US). He has made significant contributions to the field of biotechnology, particularly in the development of human hybridomas and monoclonal antibodies. His work has implications for the diagnosis of Human Immunodeficiency Virus (HIV) infection.
Latest Patents
Eskild A Peterson holds a patent for "Human hybridomas and monoclonal antibodies which bind both gp41 and gp120." This invention is directed to the human hybridoma designated MCA 86, which has A.T.C.C. Accession No. HB 9669. The human monoclonal antibodies produced by hybridoma MCA 86 immunologically bind to both gp41 and gp120 envelope glycoproteins of HIV. These monoclonal antibodies are particularly useful in the diagnosis of HIV infection. He has 1 patent to his name.
Career Highlights
Throughout his career, Eskild has worked with prominent organizations such as Teijin Limited and the University of Arizona. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Eskild A Peterson has collaborated with notable individuals in his field, including Yasuhiko Masuho and Yoh-Ichi Matsumoto. Their joint efforts have furthered the understanding and application of monoclonal antibodies in medical diagnostics.
Conclusion
Eskild A Peterson's innovative work in the field of monoclonal antibodies has made a lasting impact on HIV diagnostics. His contributions continue to influence research and development in biotechnology.